The Prompt and Fair Pay Act would require Medicare Advantage insurers to reimburse providers at traditional Medicare rates, effectively closing the payment gap between public and private plans.

A conservative lawyer is using the Comstock Act of 1873, which bans the mailing of obscene materials, to challenge the practice of sending abortion pills to states that have passed bans. 

Jamaica resident Edwin George Duffus, 65, claims the hospital discharged him after learning he didn’t have medical coverage. A federal court ruled his lawsuit can move forward.

The Department of Veterans Affairs said the new funding was made possible by its cost-saving measures, including a reduction of 30,000 staff and the consolidation of call centers.

A New York Times investigation revealed multiple incidents where patients were prepped for organ procurement while still alive, raising concerns about the influence of donation organizations.

The company said in a Securities and Exchange Commission filing that it is cooperating with the Department of Justice’s inquiry into possible incidents of Medicare Advantage upcoding.

“We are in a crisis with healthcare research, administrative burdens, and with payment. Access for our patients is hurt," said American Medical Association (AMA) Board of Trustees member Scott Ferguson, MD, FACR.

Multiple professional groups, including the American Academy of Pediatrics and the American College of Physicians, challenge recent policy changes to vaccine recommendations for COVID-19, which end routine inoculations for minors and pregnant women.

Sweeping tax cuts and reduced spending on Medicaid and SNAP were signed into law by President Donald Trump. However, a key provision that would have paused new AI regulations was removed by the Senate.

Under the proposal, Medicare would add an interventional radiology payment pathway, creating a new reporting framework for IRs as part of MIPS.

The change comes at a momentous time for the company's TAVR portfolio, which made history in May by receiving the very first FDA approval for treating asymptomatic severe AS.